Here are five points.
1. By 2022, the market will likely hit $8.04 billion, up from $6.64 billion in 2017.
2. The increasing prevalence of spinal disorder cases is driving market growth.
3. Advancing technology will increase vendor presence in the market over the next five years.
4. Poor reimbursement and strict regulations will hinder market growth, however.
5. DePuy Synthes, Alphatec Spine, Globus Medical, Orthofix, Medtronic, Zimmer Biomet and NuVasive lead the market.
More articles on devices:
DHS: Medtronic devices implanted near spine are vulnerable to security issues — 5 notes
SpineCraft announces the launch of the PANORAMA retractor
Which Medtronic business segments will experience the most growth in Q4?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
